Outcomes, risk factors associated with SARS-CoV-2 infection in North American registry of patients with MS

What The Study Did:

This analysis examined how patients with multiple sclerosis who have COVID-19 fare and what patient and disease characteristics are associated with worse outcomes.

Authors:

Amber Salter, Ph.D., of  Washington University in St Louis, is the corresponding author.

To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/

(doi:10.1001/jamaneurol.2021.0688)

Editor’s Note:

The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Media advisory:

The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

https:/

/

jamanetwork.

com/

journals/

jamaneurology/

fullarticle/

10.

1001/

jamaneurol.

2021.

0688?guestAccessKey=

d0f66c8e-e9ff-4588-95db-c24b75b0e93e&utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_content=

tfl&utm_term=

031921